Genome Editing by CRISPR-Cas: A Game Change in the Genetic Manipulation of Chlamydomonas.
Manel GhribiSerge Basile NouemssiFatma Meddeb-MouelhiIsabel Desgagné-PenixPublished in: Life (Basel, Switzerland) (2020)
Microalgae are promising photosynthetic unicellular eukaryotes among the most abundant on the planet and are considered as alternative sustainable resources for various industrial applications. Chlamydomonas is an emerging model for microalgae to be manipulated by multiple biotechnological tools in order to produce high-value bioproducts such as biofuels, bioactive peptides, pigments, nutraceuticals, and medicines. Specifically, Chlamydomonas reinhardtii has become a subject of different genetic-editing techniques adapted to modulate the production of microalgal metabolites. The main nuclear genome-editing tools available today include zinc finger nucleases (ZFNs), transcriptional activator-like effector nucleases (TALENs), and more recently discovered the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein (Cas) nuclease system. The latter, shown to have an interesting editing capacity, has become an essential tool for genome editing. In this review, we highlight the available literature on the methods and the applications of CRISPR-Cas for C. reinhardtii genetic engineering, including recent transformation methods, most used bioinformatic tools, best strategies for the expression of Cas protein and sgRNA, the CRISPR-Cas mediated gene knock-in/knock-out strategies, and finally the literature related to CRISPR expression and modification approaches.
Keyphrases
- genome editing
- crispr cas
- genome wide
- poor prognosis
- copy number
- systematic review
- binding protein
- gene expression
- dna methylation
- ms ms
- heavy metals
- wastewater treatment
- long non coding rna
- amino acid
- transcription factor
- regulatory t cells
- oxidative stress
- risk assessment
- nuclear factor
- small molecule
- immune response
- heat stress